Biosimilar Newsletter Archive

1. 09.20.18 -- 4 Revelations From FDA's Part 15 Hearing
   9/20/2018

   09/20/18 Biosimilar Development Newsletter

2. 09.13.18 -- Are Biosimilars Brazil's Waterloo?
   9/13/2018

   09/13/18 Biosimilar Development Newsletter

3. 09.12.18 -- How Automation Accelerates Biosimilar Manufacturing With Flexibility And Efficiency
   9/12/2018
   09/12/18 Biosimilar Development Newsletter
4. 09.06.18 -- The Great Canadian Biosimilar Transition
   9/6/2018

   09/06/18 Biosimilar Development Newsletter

5. 08.30.18 -- Can Biosimilars Conquer The "Emotional Hurdle?"
   8/30/2018

   08/30/18 Biosimilar Development Newsletter

6. 08.23.18 -- Biosimilar Value: The Devil Is In The Details
   8/23/2018

   08/23/18 Biosimilar Development Newsletter

7. 08.16.18 -- What To Watch In The Biosimilar Regulatory Space
   8/16/2018

   08/16/18 Biosimilar Development Newsletter

8. 08.09.18 -- EU Turns Focus To Biosimilar Sustainability Questions
   8/9/2018

   08/09/18 Biosimilar Development Newsletter

9. 08.07.18 -- Speed To Market Strategies For Biosimilar Manufacturers
   8/7/2018
   08/07/18 Biosimilar Development Newsletter
10. 08.02.18 -- Samsung Bioepis: From Biosimilars To Novel Biologics
    8/2/2018

    08/02/18 Biosimilar Development Newsletter